维普中文期刊产品整合服务
69篇 您的检索式:作者名="London WB"
    题名 作者 年代 出处 被引量
1The role of age in neu-roblastoma risk stratification:the german,Italian,and children’s oncology group perspectives显示文摘London WB Boni L Simon T 2005Cancer Lett2005,228,1:1
2The role of age in neuroblastoma risk stratification:the German,Italian,and children's oncology group perspectives显示文摘London WB Boni L Simon T 0,,1:1
3Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Be- tween Birth and 18 Months of Age显示文摘Taggart DR London WB Schmidt ML 2001J Clin Oncol2001,29,33:1
4Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study显示文摘Moreau LA McGrady P London WB 2006Clin Cancer Res2006,12,19:1
5Outcome af- ter surgery alone or with restricted use of chemotherapy for patients with low-risk netrroblastoma: results of Children/s Oncology Group study P9641 显示文摘Strother DR London WB Schmidt ML 2012J Clin Oncol2012,30,15:1
6Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease显示文摘Tebbi CK London WB Friedman D 0,,05:1
7Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma1:A report from the International Neuroblastoma Risk Group database显示文摘Bagatell R Beck-Popovie M London WB 0,,3:1
8Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study显示文摘Moreau LA McGrady P London WB 0,,19:1
9The International Neuro- blastoma Risk Group (INRG) classification system: an INRG Task Force report 显示文摘Cohn SL Pearson AD London WB 2009J Clin Oncol2009,27,2:1
10Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease显示文摘Tebbi CK London WB Friedman D 2007J Clin Oncol2007,25,5:1
11Lung metas- tases in neuroblastoma at initial diagnosis: A report from the international neuroblastoma risk group (INRG) project 显示文摘Dubois SG London WB Zhang Yang 2008Pediatr Blood Cancer2008,51,5:1
12The International Neuroblstoma Rise Group ( INRG ) Classification system:an INRG Task Force report 显示文摘Cohn SL Pearson AD London WB 2009J Clin Onco12009,27,2:1
13The International Neuroblastoma Risk Group (INRG)classification system:an INRG Task Force Report显示文摘Cohn SL Pearson AD London WB 0,,2:1
14Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplasticsyndrome and other secondary malignancies in pediatricHodgkin,s disease 显示文摘Tebbi CK London WB Friedman D 2007J Clin Oncol2007,25,3:1
15Lung metastases in neuroblastoma at initial diagnosis: A report from the international neuroblastoma risk group (INRG) project 显示文摘Dubois SG London WB Zhang Yang 2008Pediatr Blood Cancer2008,51,5:1
16The role of age in neuroblastoma risk stratification:The German,Italian,and children's oncology group perspectives显示文摘London WB Boni L Simon T 2005Cancer Lett2005,228,1:1
17Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratiication in the Children's Oncology Group 显示文摘London WB Castleberry RP Matthay KK 2005J Clin 0ncol2005,23,27:1
18Dexrazoxane-associatedrisk for acute myeloid leukemia/myelodysplastic syndrome and othersecondary malignancies in pediatric Hodgkin's disease显示文摘Tebbi CK London WB Friedman D 2007J ClinOncol2007,25,5:1
19The role of age in neuroblastoma risk stratiieation : the German, Italian, and children's oncology group perspectives 显示文摘London WB Boni L Simon T 2005Cancer Lett2005,228,12:1
20Phase ]] randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study显示文摘London WB Frantz CN Campbell LA 2010J Clin Oncol2010,28,24:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费